Bioactive materialsJun 22, 2026

Antioxidant and anti-aging complexes for treating dry eye disease

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Jun 23, 2026

Abstract

P@TCD improved tear film stability with TBUT values of more than 5.3 seconds in DED mouse models.

Oxidative stress is linked to cellular aging and damage in the corneal epithelium associated with dry eye disease.
The biocompatible supramolecular complex P@TCD reduces reactive oxygen species (ROS) accumulation and DNA damage.
P@TCD promotes cell cycle progression and decreases cellular aging in corneal epithelial cells.
In mouse models of dry eye disease, P@TCD reversed corneal epithelial defects and reduced conjunctival damage.
P@TCD aids in the recovery of lacrimal glands, contributing to improved tear film homeostasis.

Simplified

Dry eye disease (DED) is a common ocular disorder that severely impairs daily life. Oxidative stress has been identified as a key pathogenic factor driving cellular senescence and corneal epithelial damage in DED. Herein, we developed a biocompatible supramolecular complex based on the host-guest interaction of TEMPO-modified β-cyclodextrin (TCD) and puerarin (Pue), designated as P@TCD, for managing DED. The P@TCD could mitigate the ROS accumulation, reduce DNA damage, promote cell cycle progression, and attenuate cellular senescence in the corneal epithelium, thus preventing the further deterioration of DED. In two DED mouse models, P@TCD demonstrated favorable therapeutic efficacy by reversing corneal epithelial defects, alleviating conjunctival damage, and accelerating lacrimal gland recovery, thereby restoring tear film homeostasis, especially improving tear film stability with TBUT values of more than 5.3 s, compared to the DED models of less than 2.8 s, which is even more than the Cycloome® of 3.7 s. These results suggested the considerable potential of this dual ROS scavenging strategy for the effective treatment of DED.

Full Text

We can’t show the full text here under this license.

View Full Text ↗

Antioxidant and anti-aging complexes for treating dry eye disease

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief